Sarcopenia (defined by low muscle mass) as a predictor of disease progression and mortality in cardiovascular-kidney-metabolic syndrome

Sarcopenia is strongly linked to CKM syndrome severity and is a predictor of mortality across CKM stages. These findings suggest that assessing and managing sarcopenia could offer a valuable strategy to mitigate disease progression and improve survival in individuals with CKM syndrome.